Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
|Deserunt mollit sunt Lorem laborum do id aliqua dolore||20 Nov 2019||Lorem|
|Celgene’s highly restrictive Revlimid REMS may create market conundrums for generic competitors – experts||31 Oct 2017||Alaric DeArment|
|Acorda’s CVT-301 has advantages over existing options for Parkinson’s patients in congested space – experts||13 Jan 2016||Hamish McDougall|
|Amneal intends to close partnership deals in Japan, Brazil and Indonesia by YE15 - exec||10 Mar 2015||Jennifer C. Smith-Parker|
Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.
- Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
- Material intelligence on competitors, including breaking news
- Insight on companies’ business development needs and strategies
Insight on companies’ CRO and business development needs, strategies and relationships
Remove risk and uncertainty
Gain a competitive edge
Secure actionable leads
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer